Evusheld

Department of Health and Social Care written question – answered on 18th November 2022.

Alert me about debates like this

Photo of Lord Mendelsohn Lord Mendelsohn Labour

To ask His Majesty's Government, further to the report RAPID C-19 Oversight Group report: review of Evusheld by the RAPID C-19 Oversight Group, published on 6 October, how many members of the RAPID C-19 Oversight Group were (1) full time clinicians or doctors, and (2) clinicians who treat immunocompromised patients.

Photo of Lord Mendelsohn Lord Mendelsohn Labour

To ask His Majesty's Government, further to the report RAPID C-19 Oversight Group report: review of Evusheld by the RAPID C-19 Oversight Group, published on 6 October, how many members of the RAPID C-19 Oversight Group (1) have published research in the field of COVID-19, and (2) were members of SAGE and the JCVI.

Photo of Lord Mendelsohn Lord Mendelsohn Labour

To ask His Majesty's Government, further to the report RAPID C-19 Oversight Group report: review of Evusheld by the RAPID C-19 Oversight Group, published on 6 October, how many members of RAPID C-19 Oversight Group were (1) patient charity representatives, and (2) patient representatives.

Photo of Lord Markham Lord Markham The Parliamentary Under-Secretary for Health and Social Care

RAPID C-19 is a multi-agency initiative which includes representatives from the National Institute for Health and Care Research, the National Institute for Health and Care Excellence, the Medicines and Healthcare products Regulatory Agency, NHS England and the devolved administrations. Its review of Evusheld sought advice from a National Health Service expert working group and the Prophylaxis Oversight Group. RAPID C-19 contains nine clinicians with a range of expertise. While no members of RAPID C-19 or the Prophylaxis Oversight Group are immunologists, NHS expert working group has three immunology specialists.

There is one member of the Scientific Advisory Group on Emergencies in RAPID C-19 and three in the NHS expert working group and three in the Prophylaxis Oversight Group. While there are no members of the Joint Committee on Vaccination and Immunisation in RAPID C-19, it includes two scientific experts with published peer reviewed literature on COVID-19. There are no patient charity or patient representatives in RAPID C-19’s membership.

Does this answer the above question?

Yes0 people think so

No18 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.